HAL will be down for maintenance from Friday, June 10 at 4pm through Monday, June 13 at 9am. More information
Skip to Main content Skip to Navigation
Journal articles

Vedolizumab Therapy is Ineffective for Primary Sclerosing Cholangitis in Patients With Inflammatory Bowel Disease: A GETAID Multicentre Cohort Study

Benedicte Caron 1, 2 Laurent Peyrin-Biroulet 3, 4 Benjamin Pariente 5 Yoram Bouhnik 6 Philippe Seksik 7, 8 Guillaume Bouguen 9 Ludovic Caillo 10 David Laharie 11 Franck Carbonnel 12, 13 Romain Altwegg 14 Catherine Reenaers 15 Mélanie Serrero 16 Caroline Trang-Poisson 17 Stephane Nancey 18 Jérome Filippi 19 Vered Abitbol 20 Guillaume Savoye 21, 22, 23, 24 Lucine Vuitton 25 Stephanie Viennot 26 Mathurin Fumery 27 Maud Reymond 28 Jean-Pierre Bronowicki 3, 4 Jean-Marie Reimund 1, 2 Aurélien Amiot 29, 30
Complete list of metadata

https://hal-normandie-univ.archives-ouvertes.fr/hal-02363537
Contributor : Sabine Douville Connect in order to contact the contributor
Submitted on : Thursday, November 14, 2019 - 2:31:55 PM
Last modification on : Sunday, May 1, 2022 - 3:16:42 AM

Links full text

Identifiers

Citation

Benedicte Caron, Laurent Peyrin-Biroulet, Benjamin Pariente, Yoram Bouhnik, Philippe Seksik, et al.. Vedolizumab Therapy is Ineffective for Primary Sclerosing Cholangitis in Patients With Inflammatory Bowel Disease: A GETAID Multicentre Cohort Study. Journal of Crohn's and Colitis, Elsevier - Oxford University Press, 2019, 13 (10), pp.1239-1247. ⟨10.1093/ecco-jcc/jjz088⟩. ⟨hal-02363537⟩

Share

Metrics

Record views

145